(E)-1-(4-fluorophenyl)-3-(4-nitrophenyl)prop-2-en-1-one | 102692-41-1

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: (E)-1-(4-fluorophenyl)-3-(4-nitrophenyl)prop-2-en-1-one
• 英文别名: (E)-1-(4-fluorophenyl)-3-(4-nitrophenyl)-2-propen-1-one；4'-fluoro-4-nitro-trans-chalcone；4'-Fluor-4-nitro-trans-chalkon；1-(4-fluorophenyl)-3-(4-nitrophenyl)propenone
• CAS: 102692-41-1
• 化学式: C₁₅H₁₀FNO₃
• 分子量: 271.248
• InChiKey: SFJWGZZCTJKFEE-XCVCLJGOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  62.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (E)-1-(4-fluorophenyl)-3-(4-nitrophenyl)prop-2-en-1-one 在 N-(2',3',4'-trifluoro)benzyl-O(9)-allylhydrocinchoninium bromide 、 sodium hypochlorite 作用下， 以 水 、 甲苯 为溶剂， 反应 16.0h， 以90%的产率得到(4-fluorophenyl)-[(2R,3S)-3-(4-nitrophenyl)oxiran-2-yl]methanone
  参考文献：
  名称：

  Synthesis of (αR,βS)-epoxyketones by asymmetric epoxidation of chalcones with cinchona phase-transfer catalysts

  摘要：

  An efficient method to synthetically produce optically enriched (alpha R,beta S)-epoxyketones was developed using a quaternary ammonium salt derived from cinchona alkaloid as the chiral phase-transfer catalyst. (alpha R,beta S)-Epoxyketones were prepared in high optical purities (91-99% ee) by the asymmetric epoxidation of 1,3-diarylenones with aqueous sodium hypochlorite in the presence of a hydrocinchonine-derived chiral phase-transfer catalyst bearing a 2,3,4-trifluorobenzyl group. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2010.08.056
• 作为产物：
  描述：

  (4-fluorophenacyl)triphenylphosphonium bromide 在 sodium ethanolate 作用下， 以 甲苯 为溶剂， 反应 80.0h， 生成 (E)-1-(4-fluorophenyl)-3-(4-nitrophenyl)prop-2-en-1-one
  参考文献：
  名称：

  Bansal, R. K.; Mathur, Suchitra; Jain, Jainendra K., Journal of the Indian Chemical Society, 1988, vol. 65, p. 134 - 136

  摘要：

  DOI：

文献信息

• SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs
  作者：Raed Shalaby、Jacobus P. Petzer、Anél Petzer、Usman M. Ashraf、Ealla Atari、Fawaz Alasmari、Sivarajan Kumarasamy、Youssef Sari、Ashraf Khalil

  DOI：10.1080/14756366.2019.1593158

  日期：2019.1.1

  reversible competitive mode of inhibition. Most of the synthesized chalcone analogs showed a better selectivity toward MAO-B. However, introducing of 2,4,6-trimethoxy substituents on ring B shifted the selectivity toward MAO-A. In addition, we investigated the molecular mechanism of MAO-B inhibition by selected chalcone analogs. Our results revealed that these selected chalcone analogs increased dopamine levels

  抽象的 本研究描述了一系列22查尔酮类似物的合成。这些化合物被评估为潜在的人类MAO-A和MAO-B抑制剂。化合物对两种同工型表现出不同的选择性。发现IC 50值在微摩尔至亚微摩尔范围内。该ķ我化合物16的MAO-A和MAO-B抑制值分别为0.047和0.020μM。酶抑制剂混合物的透析表明抑制作用是可逆的竞争方式。大多数合成的查耳酮类似物对MAO-B表现出更好的选择性。然而，在环B上引入2,4,6-三甲氧基取代基使选择性向MAO-A转移。此外，我们研究了所选查耳酮类似物抑制MAO-B的分子机制。我们的结果表明，这些选定的查尔酮类似物可增加大鼠肝癌（H4IIE）细胞中的多巴胺水平，并降低MAO-B酶的相对mRNA表达。
• COMPOSITION FOR DIAGNOSIS OF AMYLOID-RELATED DISEASE
  申请人：Nakayama Morio

  公开号：US20100278733A1

  公开（公告）日：2010-11-04

  There is provided a composition comprising a compound represented by general formula (I), wherein R l represents a 5-iodothiophen-2-yl group or the like, and R 2 represents a 4-dimethylaminophenyl group or the like. This composition is useful for diagnosis of an amyloid-related disease such as Alzheimer's disease because the compound has high binding specificity to amyloid β protein, high permeability through the blood-brain barrier, and a property of being rapidly eliminated from sites other than senile plaques in the brain.

  提供了一种化合物组合物，其由一般式(I)所代表的化合物组成，其中R1代表5-碘噻吩-2-基基团或类似物，R2代表4-二甲氨基苯基基团或类似物。该组合物对于诊断与淀粉样蛋白相关的疾病，如阿尔茨海默病，具有高结合特异性，高透过血脑屏障的渗透性，以及在大脑老年斑以外的部位迅速被排除的特性。
• COMPOSITION FOR DIAGNOSING AMYLOID-RELATED DISEASE
  申请人：Nagasaki University

  公开号：EP2030635A1

  公开（公告）日：2009-03-04

  There is provided a composition comprising a compound represented by general formula (I), wherein R1 represents a 5-iodothiophen-2-yl group or the like, and R2 represents a 4-dimethylaminophenyl group or the like. This composition is useful for diagnosis of an amyloid-related disease such as Alzheimer's disease because the compound has high binding specificity to amyloid β protein, high permeability through the blood-brain barrier, and a property of being rapidly eliminated from sites other than senile plaques in the brain.

  提供了一种化合物组合物，其由一般式（I）表示的化合物组成，其中R1代表5-碘噻吩-2-基基团或类似物，R2代表4-二甲氨基苯基团或类似物。该组合物对于诊断与淀粉样蛋白相关的疾病，如阿尔茨海默病，具有高结合特异性，高透过血脑屏障的渗透性，以及在大脑老年斑以外部位迅速被排除的特性。
• Hybrid α-bromoacryloylamido chalcones. Design, synthesis and biological evaluation
  作者：Romeo Romagnoli、Pier Giovanni Baraldi、Maria Dora Carrion、Olga Cruz-Lopez、Carlota Lopez Cara、Jan Balzarini、Ernest Hamel、Alessandro Canella、Enrica Fabbri、Roberto Gambari、Giuseppe Basso、Giampietro Viola

  DOI：10.1016/j.bmcl.2009.02.038

  日期：2009.4

  against five cancer cell lines. Such hybrid derivatives demonstrated significantly increased anti-tumor activity compared with the corresponding amino chalcones. The most promising lead molecules were 1k, 1m and 2j, which had the highest activity toward the five cell lines. Flow cytometry with K562 cells showed that the most active compounds resulted in a large proportion of the cells entering in the apoptotic

  查尔酮抗肿瘤特性的研究在过去几年中受到了极大的关注 两个新的大型系列 α-溴丙烯酰氨基查尔酮1a - m和2a - k在其结构中包含一对迈克尔受体，对应于 α-溴丙烯酰合成部分和查尔酮框架的 α,β-不饱和酮系统，并评估其对五种癌细胞系的抗增殖活性。与相应的氨基查耳酮相比，这种杂化衍生物表现出显着增加的抗肿瘤活性。最有前途的先导分子是1k , 1m和2j 。，对五种细胞系的活性最高。K562 细胞的流式细胞术显示，活性最强的化合物导致大部分细胞进入凋亡亚 G0-G1 峰。此外，化合物1k通过线粒体途径诱导细胞凋亡并激活 caspase-3。
• A Novel Approach to 1,2-Dihydro-2-Oxo-3-Pyridinecarboxylic Ester via Aromatization Induced by Deamidation
  作者：Yuefei Hu、Gang Yu、Shaozhong Wang、Kai Wang、Hongwen Hu

  DOI：10.1055/s-2004-822325

  日期：——

  A novel approach was developed for the preparation of 4,6-disubstituted-1,2-dihydro-2-oxo-3-pyridinecarboxylic ester in moderate to good yields. This route involves a reaction sequence of Michael addition, transformation to ene-lactam, and aromatization, featuring easily available material, variable substituents, and good functional compatibility.

  开发了一种新方法用于制备4,6-二取代-1,2-二氢-2-氧-3-吡啶羧酸酯，产率中等到良好。该路线涉及迈克尔加成、转化为烯内酯和芳构化的反应序列，特点是使用的材料易得、取代基可变且功能兼容性良好。